133 related articles for article (PubMed ID: 38266443)
1. Cerebellar leptomeningeal enhancement: An imaging finding of rapidly progressive Purkinje cell cytoplasmic autoantibody type 1 paraneoplastic cerebellar syndrome.
Thakolwiboon S; Linnoila J; Pittock SJ; Dubey D; Zekeridou A
J Neuroimmunol; 2024 Feb; 387():578293. PubMed ID: 38266443
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
[TBL] [Abstract][Full Text] [Related]
3. The Discovery of Anti-Yo (Anti-PCA1) Antibody in Patients with Paraneoplastic Cerebellar Degeneration: Opening a Window into Autoimmune Neurological Disease.
Greenlee JE; Brashear HR
Cerebellum; 2023 Aug; 22(4):531-533. PubMed ID: 35881322
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity.
Panja D; Vedeler CA; Schubert M
Neuropathol Appl Neurobiol; 2019 Feb; 45(2):141-156. PubMed ID: 29679372
[TBL] [Abstract][Full Text] [Related]
5. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
[TBL] [Abstract][Full Text] [Related]
6. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
[TBL] [Abstract][Full Text] [Related]
7. Calbindin positive Purkinje cells in the pathology of human cerebellum occurring at the time of its development.
Laure-Kamionowska M; Maślińska D
Folia Neuropathol; 2009; 47(4):300-5. PubMed ID: 20054781
[TBL] [Abstract][Full Text] [Related]
8. Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications.
Yshii L; Bost C; Liblau R
Front Immunol; 2020; 11():991. PubMed ID: 32655545
[TBL] [Abstract][Full Text] [Related]
9. A Pilot Study to Develop Paraneoplastic Cerebellar Degeneration Mouse Model.
Faure F; Yshii L; Renno T; Coste I; Joubert B; Desestret V; Liblau R; Honnorat J
Cerebellum; 2024 Feb; 23(1):181-196. PubMed ID: 36729270
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic cerebellar degeneration in a patient with breast cancer associated with carbonic anhydrase-related protein VIII autoantibodies.
Prevezianou A; Tzartos JS; Dagklis IE; Bentenidi E; Angelopoulos P; Bostantjopoulou S
J Neuroimmunol; 2020 Jul; 344():577242. PubMed ID: 32325285
[TBL] [Abstract][Full Text] [Related]
11. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
Tanaka K; Tanaka M; Onodera O; Tsuji S
Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
[TBL] [Abstract][Full Text] [Related]
12. Anti-Yo positive paraneoplastic cerebellar degeneration in the setting of cholangiocarcinoma.
Bruhnding A; Notch D; Beard A
J Clin Neurosci; 2017 Feb; 36():71-72. PubMed ID: 27816258
[TBL] [Abstract][Full Text] [Related]
13. Transient Diffusion-weighted Imaging Hyperintensity of the Cerebellar Cortex in Paraneoplastic Cerebellar Degeneration.
Hashimoto Y; Komatsu K; Nakagawa T; Matsumoto S
Intern Med; 2019 Feb; 58(4):619-620. PubMed ID: 30210124
[No Abstract] [Full Text] [Related]
14. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
Tremouilhac C; Hamy A; De Ferron E; Paineau J; Visset J
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):253-6. PubMed ID: 8767221
[TBL] [Abstract][Full Text] [Related]
15. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.
Furneaux HM; Rosenblum MK; Dalmau J; Wong E; Woodruff P; Graus F; Posner JB
N Engl J Med; 1990 Jun; 322(26):1844-51. PubMed ID: 2348838
[TBL] [Abstract][Full Text] [Related]
16. Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures.
Greenlee JE; Clawson SA; Hill KE; Wood BL; Tsunoda I; Carlson NG
J Neuropathol Exp Neurol; 2010 Oct; 69(10):997-1007. PubMed ID: 20838245
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a cDNA encoding a 34-kDa Purkinje neuron protein recognized by sera from patients with paraneoplastic cerebellar degeneration.
Furneaux HM; Dropcho EJ; Barbut D; Chen YT; Rosenblum MK; Old LJ; Posner JB
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2873-7. PubMed ID: 2649898
[TBL] [Abstract][Full Text] [Related]
18. Induction of anti-Purkinje cell antibodies in vivo by immunizing with a recombinant 52-kDa paraneoplastic cerebellar degeneration-associated protein.
Sakai K; Gofuku M; Kitagawa Y; Ogasawara T; Hirose G
J Neuroimmunol; 1995 Jul; 60(1-2):135-41. PubMed ID: 7642741
[TBL] [Abstract][Full Text] [Related]
19. A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration.
Anderson NE; Budde-Steffen C; Wiley RG; Thurman L; Rosenblum MK; Nadeau SE; Posner JB
Neurology; 1988 Jul; 38(7):1018-26. PubMed ID: 3290700
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen.
Jaeckle KA; Graus F; Houghton A; Cardon-Cardo C; Nielsen SL; Posner JB
Ann Neurol; 1985 Nov; 18(5):592-600. PubMed ID: 2416270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]